NASSA, Giovanni
 Distribuzione geografica
Continente #
AS - Asia 7.220
NA - Nord America 5.832
EU - Europa 1.943
SA - Sud America 314
Continente sconosciuto - Info sul continente non disponibili 294
AF - Africa 65
OC - Oceania 7
Totale 15.675
Nazione #
US - Stati Uniti d'America 5.655
HK - Hong Kong 5.301
SG - Singapore 870
IT - Italia 840
CN - Cina 423
RU - Federazione Russa 242
BR - Brasile 239
VN - Vietnam 235
DE - Germania 202
UA - Ucraina 130
CA - Canada 100
IE - Irlanda 86
FR - Francia 82
TR - Turchia 81
GB - Regno Unito 73
SE - Svezia 72
IN - India 69
KR - Corea 67
FI - Finlandia 61
NL - Olanda 41
JP - Giappone 35
BD - Bangladesh 34
PL - Polonia 28
MX - Messico 27
AR - Argentina 26
AT - Austria 19
IQ - Iraq 18
SA - Arabia Saudita 18
ZA - Sudafrica 18
ES - Italia 14
CO - Colombia 13
CZ - Repubblica Ceca 13
MA - Marocco 12
UZ - Uzbekistan 12
VE - Venezuela 10
ID - Indonesia 9
PH - Filippine 9
PK - Pakistan 9
EC - Ecuador 8
TT - Trinidad e Tobago 7
CR - Costa Rica 6
CL - Cile 5
DK - Danimarca 5
EG - Egitto 5
GT - Guatemala 5
JM - Giamaica 5
KE - Kenya 5
PR - Porto Rico 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
BO - Bolivia 4
CW - ???statistics.table.value.countryCode.CW??? 4
HN - Honduras 4
HU - Ungheria 4
IL - Israele 4
KZ - Kazakistan 4
LV - Lettonia 4
SV - El Salvador 4
TN - Tunisia 4
AL - Albania 3
BE - Belgio 3
CH - Svizzera 3
EU - Europa 3
GR - Grecia 3
HR - Croazia 3
JO - Giordania 3
MY - Malesia 3
NI - Nicaragua 3
PE - Perù 3
BH - Bahrain 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
LT - Lituania 2
LY - Libia 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AG - Antigua e Barbuda 1
AO - Angola 1
AW - Aruba 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
CV - Capo Verde 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GM - Gambi 1
GP - Guadalupe 1
Totale 15.368
Città #
Hong Kong 5.294
Ann Arbor 752
San Jose 694
Dallas 662
Singapore 476
Chandler 369
Ashburn 343
Woodbridge 252
Milan 231
Princeton 200
Jacksonville 170
Wilmington 160
Houston 156
Council Bluffs 148
Beijing 114
Salerno 93
The Dalles 85
Munich 84
Santa Clara 83
Dublin 78
New York 78
Lauterbourg 67
Los Angeles 67
Ho Chi Minh City 63
Naples 59
Rome 57
Hanoi 49
Izmir 49
Andover 42
Nanjing 38
Dearborn 37
Boardman 35
Tokyo 35
Montreal 33
Moscow 33
Dong Ket 32
Atlanta 26
São Paulo 26
Pellezzano 25
Turku 25
Warsaw 25
Chicago 24
Memphis 24
Denver 23
Fairfield 23
Figino 20
Frankfurt am Main 20
Orem 20
Phoenix 20
Shenyang 20
Brooklyn 19
Fisciano 18
London 18
Nuremberg 18
Stockholm 17
Amsterdam 16
Changsha 16
Columbus 16
Washington 16
Mercato San Severino 15
Boston 14
San Francisco 14
Seattle 14
Nürnberg 13
Philadelphia 13
Poplar 13
Hebei 12
Brno 11
Jinan 11
Turin 11
Vienna 11
Calgary 10
Chennai 10
Da Nang 10
Düsseldorf 10
Guangzhou 10
Ankara 9
Mexico City 9
Redwood City 9
Sarno 9
Seoul 9
Tashkent 9
Buffalo 8
Charlotte 8
Falls Church 8
Helsinki 8
Johannesburg 8
Norwalk 8
Rio de Janeiro 8
Tianjin 8
Toronto 8
Zhengzhou 8
Bogotá 7
Jeddah 7
Manchester 7
New Delhi 7
Renton 7
Riyadh 7
Baghdad 6
Bari 6
Totale 12.083
Nome #
Small non-coding RNA deregulation in endometrial carcinogenesis 1.127
The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei 732
Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: Identification of novel nuclear cofactors of antiestrogen-ERα complexes by interaction proteomics. 564
WIND (Workflow for pIRNAs aNd beyonD): a strategy for in-depth analysis of small RNA-seq data 518
Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer 516
Global View of Candidate Therapeutic Target Genes in Hormone-Responsive Breast Cancer 506
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis 487
Host nasopharyngeal transcriptome dataset of a SARS-CoV-2 positive Italian cohort 466
Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma 416
Small non-coding RNA transcriptomic profiling in adult and fetal human brain 346
Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers 268
Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer 250
Identification of cytoplasmic proteins interacting with unliganded estrogen receptor α and β in human breast cancer cells 229
Splicing of platelet resident pre-mRNAs upon activation by physiological stimuli results in functionally relevant proteome modifications. 229
The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading 214
iSmaRT: a toolkit for a comprehensive analysis of small RNA-Seq data 211
Non-coding RNA profiling in BRaFV600E-mutant cutaneous melanoma before and after Spry1 depletion 210
Small RNA profiling reveals deregulated PTEN/PI3K/Akt pathway in asthmatic bronchial smooth muscle cells. 203
Effects of Oestrogen on MicroRNA Expression in Hormone-Responsive Breast Cancer Cells 201
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 200
Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy 196
Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies 196
A large set of estrogen receptor beta-interacting proteins identified by tandem affinity purification in hormone-responsive human breast cancer cells nuclei. 191
Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. 186
Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations. 184
Global Analysis of Estrogen Receptor Beta Binding to Breast Cancer Cell Genome Reveals Extensive Interplay with Estrogen Receptor Alpha for Target Gene Regulation. 181
Comparative analysis of nuclear estrogen receptor alpha and beta interactomes in breast cancer cells. 180
Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells 176
Glucose Deprivation Promotes Pseudohypoxia and Dedifferentiation in Lung Adenocarcinoma 175
Global gene expression profile of normal and regenerating liver in young and old mice 175
Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma 173
Carcinogenic risk and Bisphenol A exposure: A focus on molecular aspects in endoderm derived glands 163
Identification of a hormone-regulated dynamic actin network associated with estrogen receptor alpha in human breast cancer cell nuclei. 160
Atrial myxomas arise from multipotent cardiac stem cells 159
Single-cell states in the estrogen response of breast cancer cell lines. 156
Large-scale profiling of signalling pathways reveals an asthma specific signature in bronchial smooth muscle cells 156
Interaction Proteomics Identifies ERbeta Association with Chromatin Repressive Complexes to Inhibit Cholesterol Biosynthesis and Exert An Oncosuppressive Role in Triple-negative Breast Cancer 156
Timed regulation of P-Element-Induced Wimpy Testis-interacting RNA expression during rat liver regeneration. 155
New Insights on Estrogen Receptor Actions in Hormone-responsive Breast Cancer Cells by Interaction Proteomics 154
Post-transcriptional regulation of human breast cancer cell proteome by unliganded Estrogen Receptor beta via microRNAs. 148
RNA sequencing identifies specific PIWI-interacting small non-coding RNA expression patterns in breast cancer. 147
Global transcriptome profiles of Italian Mediterranean buffalo embryos with normal and retarded growth. 147
Identification of long non‑coding RNA expression patterns useful for molecular‑based classification of type I endometrial cancers 147
MicroRNA (miRNA) and piwi-interacting RNA (piRNA) signature of human primary bronchial epithelial cells (PBEC) after exposure to mainstream cigarette smoke (MCS) 147
iMir: an integrated pipeline for high-throughput analysis of small non-coding RNA data obtained by smallRNA-Seq. 145
Identification of proteins associated with ligand-activated estrogen receptor alpha in human breast cancer cell nuclei by tandem affinity purification and nanoLC-MS/MS. 145
The "busy life" of unliganded estrogen receptors 144
Inhibition of histone methyltransferase DOT1L silences ER gene and blocks proliferation of antiestrogen-resistant breast cancer cells 144
Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors 144
Quantitative mapping of RNA-mediated nuclear Estrogen Receptor β interactome in human breast cancer cells 143
Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: A possible contribution of immunity to thrombosis? 141
Molecular and Functional Characterization of the Somatic PIWIL1/piRNA Pathway in Colorectal Cancer Cells 128
HOME-BIO (sHOtgun MEtagenomic analysis of BIOlogical entities): a specific and comprehensive pipeline for metagenomic shotgun sequencing data analysis 128
PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach 126
An overview of candidate therapeutic target genes in ovarian cancer 125
Identification of Antiestrogen-Bound Estrogen Receptor α Interactomes in Hormone-Responsive Human Breast Cancer Cell Nuclei 124
Lack of pathogenic mutations in six patients with MMPSI. 123
Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer 118
Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes 115
TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness 115
Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer 113
LncRNA PVT1 links estrogen receptor alpha and the polycomb repressive complex 2 in suppression of pro-apoptotic genes in hormone-responsive breast cancer 111
Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers 111
Whole Genome Sequence Dataset of Mycobacterium tuberculosis Strains from Patients of Campania Region 107
BRPF1 in cancer epigenetics: a key regulator of histone acetylation and a promising therapeutic target 105
KCTD15 is overexpressed in human childhood B-cell acute lymphoid leukemia 104
Genome-wide DNA methylation changes upon DOT1L inhibition in hormone-responsive breast cancer cells 102
BRPF1 inhibition reduces migration and invasion of metastatic ovarian cancer cells, representing a potential therapeutic target 102
Regulation of metabolic reprogramming by long non-coding rnas in cancer 102
The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells 99
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC 96
Functional Relationships between Long Non-Coding RNAs and Estrogen Receptor Alpha: A New Frontier in Hormone-Responsive Breast Cancer Management 94
Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer 92
Caratterizzazione genomica e trascrittomica di tumori neuroendocrini gastro-enteropancreatici 82
Castalin Induces ROS Production, Leading to DNA Damage and Increasing the Activity of CHK1 Inhibitor in Cancer Cell Lines 81
RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer 77
Identification of LncRNAs scaffolding a chromatin-associated gene regulatory complex in breast cancer cells comprising ERα, DOT1L and menin 39
Epigenetic alterations of AKT1 orchestrate a metabolic reprogramming in advanced lipedema: translational insights from an integrated multi-omics study 39
Editorial: Chromatin modifications and gene expression: from mechanisms to therapeutic implications in disease 10
Totale 15.675
Categoria #
all - tutte 42.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.123


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022360 0 0 0 1 34 6 3 9 48 42 56 161
2022/2023819 62 94 37 113 79 129 10 96 131 6 44 18
2023/2024424 30 42 34 16 31 74 59 14 9 23 20 72
2024/20251.189 20 11 7 37 80 132 233 87 195 73 176 138
2025/20269.446 837 2.521 2.878 351 534 267 576 113 418 451 119 381
2026/2027998 193 135 326 344 0 0 0 0 0 0 0 0
Totale 15.675